본문 바로가기
KERD
논문KCI 등재

A Fifteen-year Epidemiological Study of Ventriculoperitoneal Shunt Infections in Pediatric Patients: A Single Center Experience

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Purpose : Ventriculoperitoneal (VP) shunt insertion is an important treatment modality in children with hydrocephalus. VP shunt infection is a major complication and an important factor that determines the surgery outcome. This 15-year study was performed to evaluate the epidemiology of VP shunt infections in pediatric patients treated at our center. Methods : A retrospective review of medical records was performed in patients 18 years old or younger who underwent VP shunt insertion surgery from April 1995 to June 2010. Results : Three hundred twenty-seven VP shunt surgeries were performed in a total of 190 pediatric patients (83 females,107 males). The median age of the patients was 2.4 years (range, 0.02-17.9 years). Having a malignant brain tumor was the most frequent cause for VP shunt insertion. The shunt infection rate was 6.7% (22/327) per 100 operations and 9.5%(18/190) per 100 patients, and the incidence rate was 0.45 infection cases per 100 shunt operations-year. The most common pathogen was coagulase-negative staphylococcus (n=7) followed by methicillin resistant Staphylococcus aureus (n=1). Ten cases were treated with vancomycin and beta-lactam antibiotic (cephalosporin or carbapenem) combination therapy and 7 cases were treated with vancomycin monotherapy. The median duration of antibiotic treatment was 26 days (range, 7to 58 days). Surgical intervention was performed in 18 cases (18/22, 81.8%). Conclusion : Epidemiologic information regarding VP shunt infections in pediatric patients is valuable that will help guide proper antibiotic management. Additional studies on the risk factors for developing VP shunt infections are also warranted.

Abstract

Purpose : Ventriculoperitoneal (VP) shunt insertion is an important treatment modality in children with hydrocephalus. VP shunt infection is a major complication and an important factor that determines the surgery outcome. This 15-year study was performed to evaluate the epidemiology of VP shunt infections in pediatric patients treated at our center. Methods : A retrospective review of medical records was performed in patients 18 years old or younger who underwent VP shunt insertion surgery from April 1995 to June 2010. Results : Three hundred twenty-seven VP shunt surgeries were performed in a total of 190 pediatric patients (83 females,107 males). The median age of the patients was 2.4 years (range, 0.02-17.9 years). Having a malignant brain tumor was the most frequent cause for VP shunt insertion. The shunt infection rate was 6.7% (22/327) per 100 operations and 9.5%(18/190) per 100 patients, and the incidence rate was 0.45 infection cases per 100 shunt operations-year. The most common pathogen was coagulase-negative staphylococcus (n=7) followed by methicillin resistant Staphylococcus aureus (n=1). Ten cases were treated with vancomycin and beta-lactam antibiotic (cephalosporin or carbapenem) combination therapy and 7 cases were treated with vancomycin monotherapy. The median duration of antibiotic treatment was 26 days (range, 7to 58 days). Surgical intervention was performed in 18 cases (18/22, 81.8%). Conclusion : Epidemiologic information regarding VP shunt infections in pediatric patients is valuable that will help guide proper antibiotic management. Additional studies on the risk factors for developing VP shunt infections are also warranted.

참고문헌 (32)

  1. Di Rocco C, "Shunts vs endoscopic third ventriculostomy in infants: are there different types and", or rates of complications? A review, 2006, pp.22, 1573~1589
  2. Owen R, "Delayed external ventriculoperitoneal shunt infection", J Ky Med Assoc, 102, pp.349~352 (2004)
  3. Chadduck W, "Incidence of seizures in patients with myelomeningocele: a multifactorial analysis", Surg Neurol, 30, pp.281~285 (1988)
  4. Walters BC, "Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome", J Neurosurg, 60, pp.1014~1021 (1984)
  5. Prusseit J, "Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children", Pediatr Neurosurg, 45, pp.325~336 (2009)
  6. Anderson EJ, "A rational approach to the management of ventricular shunt infections", Pediatr Infect Dis J, 24, pp.557~558 (2005)
  7. Choux M, "Shunt implantation: reducing the incidence of shunt infection", J Neurosurg, 77, pp.875~880 (1992)
  8. Key CB, "Cerebrospinal fluid shunt complications: an emergency medicine perspective", Pediatr Emerg Care, 11, pp.265~273 (1995)
  9. Rowin ME, "Pediatric intensive care unit nosocomial infections: epidemiology, sources and solutions", Crit Care Clin, 19, pp.473~487 (2003)
  10. Conen A, "Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period", Clin Infect Dis, 47, pp.73~82 (2008)
  11. James HE, "The management of cerebrospinal fluid shunt infections: a clinical experience", Acta Neurochir, 59, pp.157~166 (1981)
  12. James HE, "Prospective randomized study of therapy in cerebrospinal fluid shunt infection", Neurosurgery, 7, pp.459~463 (1980)
  13. Schreffler RT, "Treatment of cerebrospinal fluid shunt infections: a decision analysis", Pediatr Infect Dis J, 21, pp.632~636 (2002)
  14. Tunkel AR, "Practice guidelines for the management of bacterial meningitis", Clin Infect Dis, 39, pp.1267~1284 (2004)
  15. Whitehead WE, "The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons", Pediatr Neurosurg, 35, pp.205~210 (2001)
  16. McClinton D, "Predictors of ventriculoperitoneal shunt pathology", Pediatr Infect Dis J, 20, pp.593~597 (2001)
  17. McGirt MJ, "Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens", Clin Infect Dis, 36, pp.858~862 (2003)
  18. Reddy GK, "Ventriculoperitoneal shunt surgery and the incidence of shunt revision in adult patients with hemorrhage- related hydrocephalus", Clin Neurol Neurosurg, 114, pp.1211~1216 (2012)
  19. Garner JS, "CDC definitions for nosocomial infections 1988", Z Arztl Fortbild (Jena), 85, pp.818~827 (1991)
  20. Horan TC, "CDC", NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, 2008, pp.36, 309~332
  21. Bokhary MA, "Ventriculo-peritoneal shunt infections in infants and children", Libyan J Med, 3, pp.20~22 (2008)
  22. Baird C, "Late shunt infections", Pediatr Neurosurg, 31, pp.269~273 (1999)
  23. Braga MH, "Early shunt complications in 46 children with hydrocephalus", Arq Neuropsiquiatr, 67, pp.273~277 (2009)
  24. Enger PØ, "Shunt revisions in children--can they be avoided? Experiences from a population-based study", Pediatr Neurosurg, 41, pp.300~304 (2005)
  25. Kontny U, "CSF shunt infections in children", Infection, 21, pp.89~92 (1993)
  26. Mancao M, "Cerebrospinal fluid shunt infections in infants and children in Mobile", Alabama. Acta Paediatr, 97, pp.667~670 (1998)
  27. Odio C, "CSF shunt infections in pediatrics. A seven-year experience", Am J Dis Child, 138, pp.1103~1108 (1984)
  28. Stevens NT, "Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: pathogenesis and implications for treatment", Br J Neurosurg, 26, pp.792~797 (2012)
  29. Olson ME, "Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm", J Antimicrob Chemother, 65, pp.2164~2171 (2010)
  30. Silva LV, "Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains", Mem Inst Oswaldo Cruz, 106, pp.44~50 (2011)
  31. Simon TD, "Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States", Clinical article. J Neurosurg Pediatr, 4, pp.156~165 (2009)
  32. Tuan TJ, "Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children", Pediatr Infect Dis J, 30, pp.731~735 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (7건)